Thermosensitive liposomes: a promising step toward localised chemotherapy
Maryam Chaudhry1, Paul Lyon2,3, Constantin Coussios4
1Kellogg College, University of Oxford, Oxford, UK.
Expert Opinion on Drug Delivery
|July 13, 2022
Summary
Targeted drug delivery for solid tumors is improved using heat-responsive liposomal carriers. External stimuli like mild hyperthermia enhance drug release and deposition, optimizing therapeutic outcomes.
Area of Science:
- Oncology
- Nanotechnology
- Drug Delivery
Background:
- Solid tumor therapy faces challenges with inefficient drug delivery due to unique tumor physiology.
- Conventional nanoscale drug carriers show limited tumor accumulation and drug release.
- Redesigned carriers are now paired with external stimuli to enhance drug deposition.
Purpose of the Study:
- To assess the progress of thermolabile drug carrier systems.
- To evaluate modalities used to trigger drug release from these carriers.
Main Methods:
- Review of pre-clinical and clinical data on thermolabile drug carriers.
- Analysis of external stimuli, specifically mild hyperthermia, for triggering drug release.
Main Results:
- Heat-responsive liposomal drug carriers combined with mild hyperthermia show significant potential.
- Clinical trials are ongoing to refine these technologies for optimal patient benefit.
Conclusions:
- The combined approach of mild hyperthermia and heat-responsive liposomes offers a promising strategy for enhanced solid tumor therapy.
- Further clinical refinement of dosing and exposure parameters is crucial for maximizing therapeutic efficacy.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...